TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Love Pharma Inc ( (TSE:JOLT) ) has shared an announcement.
Jolt Health Inc. announced a consolidation of its common shares, approved by shareholders and its Board, to enhance flexibility for future financing opportunities. The consolidation will see a 20:1 share ratio change, reducing the number of shares and aligning warrants and options accordingly, pending Canadian Securities Exchange approval.
More about Love Pharma Inc
Jolt Health Inc. is a leading life sciences company focused on healthcare, biotechnology, and artificial intelligence. It holds exclusive licenses for innovative therapeutic and pharmaceutical products across Europe, the UK, and North America. The company is committed to transforming the healthcare industry through research, collaboration, and technological advancement.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$636.4K
See more data about JOLT stock on TipRanks’ Stock Analysis page.